Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X1LO
|
||||
Former ID |
DIB016292
|
||||
Drug Name |
EMR-62203
|
||||
Synonyms |
EMR-6203; PDE 5 inhibitor, Merck KGaA
|
||||
Indication | Erectile dysfunction [ICD9: 302.72, 607.84; ICD10:F52.2, N48.4] | Discontinued in Phase 2 | [547732] | ||
Company |
Merck KGaA
|
||||
Target and Pathway | |||||
Target(s) | CGMP-specific 3',5'-cyclic phosphodiesterase | Target Info | Inhibitor | [550125] | |
KEGG Pathway | Purine metabolism | ||||
cGMP-PKG signaling pathway | |||||
NetPath Pathway | TGF_beta_Receptor Signaling Pathway | ||||
Reactome | cGMP effects | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.